Viatris

U.S. pharmaceutical company Viatris has been fined 7.58 million dirhams ($760,000) by Morocco's competition authority for failing to notify the regulator of its merger, according to two anonymous sources cited by...

Viatris announced on Tuesday that its subsidiary, Mylan, is no longer a subject of the U.S. DOJ antitrust investigation into alleged price fixing within the generic drug industry. This development...

The US Supreme Court declined to consider Sanofi SA’s antitrust lawsuit against Viatris Inc, alleging that the latter had illegally monopolized the market with its EpiPen auto-injector, a device used to treat severe allergic reactions, reported Reuters.  The Supreme Court declined to hear Sanofi’s appeal regarding their accusation that Viatris had monopolized the market by making […]

Viatris, the drugmaker formerly known as Mylan, said on Monday it had agreed to pay $264 million to resolve a class action lawsuit alleging it engaged in a scheme to delay generic competition to its EpiPen allergy treatment, reported Reuters.  The proposed settlement would resolve litigation that began following public outrage in 2016 over Mylan’s decision […]

According to FiercePharma, Viatris, the drugmaker announced that it’s scored a win against serious charges in an antitrust case that’s been running for several years. Viatris Gets A Win In Long-Running EpiPen Antitrust Suit . Viatris, the newly-formed company that combined Mylan and Pfizer’s Upjohn unit late last year, stated it’s “pleased” with the Kansas District Court’s […]